Key factors
sym0N5Z
exchLSE
MCap9097.09K
Beta0.507
PE Ratio0.030
EPS8.0
Div1.08
Div Yld4.529
Yesterday
sym0N5Z
exchLSE
close24.61
50 Day MA26.10
200 Day MA26.38
52 Week High28.0
52 Week Low23.6
Market Cap Mln9.097
Share statistics
Shares Outstanding36.48M
Shares Float10.89M
Percent Institutions2.535
PercentInsiders70.08
Revenue TTM 81.4M
Revenue Per Share TTM 0.003
Quarterly Revenue Growth YOY 164.80
Gross Profit TTM -12.4M
EBITDA40.37M
Diluted Eps TTM8.0
Quarterly Earnings Growth YOY-94.4
earning
Operating Margin TTM 0.528
Trailing PE 0.030
Earnings Share 8.0
Dividend
Forward Annual Dividend Yield 4.080
business
Book Value /share 35.95
Price Sales TTM 0.111
ProfitMargin 0.347
ReturnOnAssetsTTM 0.015
ReturnOnEquityTTM0.021
Gic GroupCommercial & Professional Services
Gic IndustryCommercial Services & Supplies
Gic Sector Industrials
Gic Sub Industry Environmental & Facilities Services
Code 0N5Z
CountryISO GB
Currency CodeEUR
Currency Name Euro
Exchange LSE
Currency Symbol
Type Common Stock
UpdatedAt 2024-04-25
Fiscal Year End December
MostRecent Quarter2023-06-30
Contact
NameAltamir SCA
Address1 rue Paul Cézanne, Paris, France, 75008
Country NameUK
Phone33 1 53 65 01 00
Web URLhttps://www.altamir.fr/fr/
Altamir SCA, formerly known as Altamir Amboise, is a private equity investment arm of Amboise SAS, specializing in both direct and fund of fund investments, small and mid-cap companies. In direct investing, the firm specializes in middle market, buyout and growth capital investments. The firm prefers to invest in under-developed divisions of larger corporations. It prefers to invest in private equity funds specializing in growth capital and leverage buyouts investments from Europe, United States and Canada. The firm typically invests in the following sectors: healthcare, TMT, digital companies, consumer services, education services, retail and distribution. It also invests in retail and consumer, business and financial services. In healthcare, it seeks to focus on companies with strong growth potential in areas such as health services (hospitalization structures, home health care and medical analysis); medical devices; in niche pharmaceutical laboratories; and companies in related activities such as dermo-cosmetics, galenic development, and services and databases for health organizations. The firm seeks to invest in unlisted companies based in Europe, with a particular focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, Netherlands, Germany and French-speaking Europe; United States and Canada and in larger emerging markets such as China, India and Brazil. In small and mid-cap companies firm prefers to invest in Continental Europe with a focus in France, Italy and Benelux, & larger size companies in Europe, North America and emerging countries like China, India and Brazil. In small and mid-cap size companies it prefers to invest with enterprise value between "50 million ($55.36 million) and "500 million ($553.6 million) and in larger size companies it prefers to invest with enterprise value between "500 million ($553.60 million) and "3000 million ($3321.62 million). It invests in funds that seek to have a majority stake in its investments or be a lead shareholder. It invests and disinvests with the p